PCML
BIIB icon

Pavaki Capital Management LLC’s Biogen BIIB Stock Holding History

Pavaki Capital Management LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$756K Hold
3,500
– – 0.26% 68
2026
Q1 		$642K Hold
3,500
– – 0.27% 63
2025
Q4 		$616K Buy
+3,500
New +$572K 0.24% 57

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Pavaki Capital Management LLC's BIIB Position: Q2 2026 in Review

Pavaki Capital Management LLC held its Biogen (BIIB) position steady in Q2 2026 at 3,500 shares worth $756K. The position accounts for 0.26% of the portfolio, ranked #68.

Pavaki Capital Management LLC first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Pavaki Capital Management LLC held 3,500 shares of Biogen worth $756K as of Q2 2026.
  • Pavaki Capital Management LLC left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.26% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #68 holding.
  • Pavaki Capital Management LLC first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.